Delivery Order SPE2DB20D1100-SPE2DB24FD5E5

Award Date 8/28/24
Potential Completion Date 8/29/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,033.17, is for the delivery of an ADVAIR HFA 115-21 MCG INHALER 12GM medication. The contract has an ultimate completion date of May 22, 2024 and is a firm fixed-price delivery order. The contract is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, with a ceiling value of $2,605.55 and a period of performance through July 9, 2024. The contract is a Firm Fixed Price vehicle, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,431.02 and is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a prescription medication. The contract is a firm fixed-price, non-set-aside award with a period of performance running through June 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, with a ceiling value of $15,129.35 and a period of performance through July 9, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The contract has a ceiling value of $16,287.03 and an ultimate completion date of August 1, 2024. It is a firm-fixed-price contract with no set-aside designation. This contract represents a task order or delivery under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,204.80 firm-fixed-price contract is for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product. The contract has a completion date of November 17, 2022 and was awarded on November 16, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a prescription medication. The contract has a ceiling value of $3,070.68 and is a firm fixed-price delivery order, with a period of performance through May 6, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,315.96 firm fixed price contract is for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM medical products. This delivery order is placed under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that provides a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a respiratory medication, and has a ceiling value of $73,209.55. The contract is a firm fixed-price, delivery order contract with a period of performance through January 7, 2025. The contract was not set aside for any specific business type. AmerisourceBergen holds a larger...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM. The contract has a Ceiling Value of $8,563.20 and an Ultimate Completion Date of April 1, 2025. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD5E5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply ADVAIR HFA 115-21 MCG INHALER 12GM. The award has a ceiling value of $14,598.68 and an ultimate completion date of August 29, 2024. The contract is a firm fixed-price delivery order, indicating that AmerisourceBergen will provide the specified quantity of inhalers at a predetermined price. This contract does not have a set-aside designation. AmerisourceBergen has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to supply a wide range of pharmaceutical and medical products to support military treatment programs and federal healthcare needs.

Generated 11/27/24, 9:13 AM